MedPath

POMBILITI

POMBILITI

Approved
DIN Number

02556898

Drug Class

Human

Market Date

N/A

Company
HC

Amicus Therapeutics Canada Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02556898
AIG Number0166744001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
A16AB23 CIPAGLUCOSIDASE ALFA
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CIPAGLUCOSIDASE ALFAActive
Strength: 105 MG / VIAL
Monograph: CIPAGLUCOSIDASE ALFA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.